As Reuters reports, the weight loss market is ripe for new blood considering that Novo Nordisk, the maker of Wegovy and its diabetes sister drug Ozempic, and Eli Lilly, which makes the analog weight management drugs Zepbound and Mounjaro, have not been able to produce enough of their name-brand versions to meet demand
Liraglutide was approved for clinical use in Europe in 2009 and in the USA in 2010
Hydrating vitamins and minerals are tailored for optimal hydration and detoxification
GLP-1 medications must be discontinued before conception
Eat a well-balanced diet, exercise often, and don't use tobacco products
Restrictive insurance policies, such as step therapy and prior authorization, which add hurdles for patients